Biograil Undisclosed stage: €20M

Nov 4, 2026Public sources — Collected from public sources, not yet cross-checked.

Biograil raised €20 million (about $22.36 million) in an undisclosed stage round led by Verve Ventures and Megatrend Invest, announced Nov. 4.

Facts

Company: Biograil
Amount: €20 million (about $22.36 million)
Currency: EUR
Stage: Undisclosed stage
Announced: Nov 4, 2026
FX rate: 1 EUR = 1.1179 USD on Nov 3, 2026

Investors

Led by: Verve Ventures Megatrend Invest
Participants: High-Tech Gründerfonds

Use of funds

Support ongoing activities for planned Phase 1 clinical testing of BIONDD, achieve non-clinical GLP studies, and establish manufacturing GMP process.

As stated by the company.

Sources

1.Copenhagen’s Biograil raises €20 million for oral drug delivery device designed as an alternative to injections — EU-Startups, Nov 4, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Nov 4, 2026